- Original Article
- Open Access
Characteristics and outcomes of anterior mediastinal cystic lesions diagnosed on chest MRI: implications for management of cystic lesions
Insights into Imaging volume 13, Article number: 136 (2022)
Chest MRI is a useful diagnostic modality for the evaluation of anterior mediastinal lesions but the outcomes of anterior mediastinal cystic lesions diagnosed on chest MRI are unclear.
In this multicenter retrospective study, patients who underwent contrast-enhanced chest MRI in two tertiary centers to assess anterior mediastinal cystic lesions were included after excluding overt solid tumors and thymic hyperplasia. Anterior mediastinal cystic lesions were classified into two categories: probable (simple) cyst or indeterminate lesion (complex cyst). Size and imaging features of lesions during follow-up were evaluated and clinical outcomes were assessed.
A total of 204 patients (mean age, 59 ± 11 years; M:F = 111:93) were studied; 186 (91.2%) were classified as probable cysts and 18 (8.8%) as indeterminate lesions on MRI. Among patients with probable cysts and more than 2 years of follow-up, lesion size was unchanged in 39.6% (36/91), decreased in 16.5% (15/91), and fluctuated in 8.8% (8/91). All patients who underwent surgery were confirmed cysts. None developed mural nodules or irregular wall thickening, suspicious for malignancy during follow-up. In patients with indeterminate lesions, 16.7% (3/18) had pathologically confirmed thymoma and 44.4% (8/18) had proven cysts. Follow-up numbers and intervals after MRI in patients with probable cysts were variable among physicians and institutions in clinical practice (p < 0.05) but more than half were followed for up to 2 years in two centers.
Diagnosing anterior mediastinal cysts using MRI is reliable. MRI-based management of anterior mediastinal lesions may reduce the number of unnecessary follow-ups and surgeries.
Diagnosing anterior mediastinal cysts using MRI is reliable.
None of probable cysts on MRI turned out to be tumors.
For indeterminate lesions, short-term follow-up can be recommended prior to surgery.
MRI-based management may reduce the unnecessary follow-ups and surgeries.
With the increasing use of chest CT in routine clinical practice and cancer screening, asymptomatic anterior mediastinal lesions are being detected more frequently. The prevalence of incidental anterior mediastinal lesions is reported to be 0.5–0.9% [1,2,3]. The most prevalent benign disease for anterior mediastinal lesions is a thymic cyst, and malignancies such as thymic epithelial tumors are a primary concern for incidental anterior mediastinal lesions. Diagnosing asymptomatic anterior mediastinal lesions based on CT findings is often challenging, as the lesions can lack distinguishable CT features owing to their small size, ovoid shape, and CT attenuation higher than 20 Hounsfield units [2, 4]. Although thymoma grows with a wide range of volume doubling times [5, 6], thymic cyst also can show growth on follow-up . Moreover, because of their location, small anterior mediastinal lesions are not always readily accessible by percutaneous biopsy, occasionally causing patients to undergo unnecessary thymectomy for ultimately benign disease.
Chest magnetic resonance imaging (MRI) is a useful diagnostic modality that can help distinguish cystic from solid thymic lesions that are indeterminate on CT [8, 9]. The International Thymic Malignancy Interest Group (ITMIG) suggested the use of MRI for work up and also follow-up of suspected anterior mediastinal cystic lesion . Reported diagnostic accuracy in differentiating non-neoplastic cyst from malignant tumor using chest MRI is 71–91% [9, 11, 12]. However, the guidelines did not clearly describe how to manage suspected anterior mediastinal cystic lesions on MRI in terms of follow-up interval or duration. Recently, Ackman et al. demonstrated the longitudinal change of unilocular thymic cysts defined by MRI, which showed changes in size and morphologic features without definite malignant transformation . However, we also occasionally encounter multilocular cystic lesions or cystic lesions with nodular or eccentric wall thickening on imaging which are also clinically significant for patient management but not evaluated in the previous study. Therefore, we aimed to evaluate the follow-up outcome in patients with anterior mediastinal cystic lesions stratified based on MRI findings, and assess the clinical implication of chest MRI for the management of anterior mediastinal cystic lesions.
Materials and methods
This retrospective study was approved by the institutional review boards, and the requirement for informed consent was waived (IRB Numbers: 2021-0402, 2021-02-156).
Study design and patients
In this multicenter study, consecutive patients who underwent contrast-enhanced chest MRI for the evaluation of anterior mediastinal lesion manifesting as a cystic lesion were included from January 2012 to June 2019 at Asan Medical Center (institution A) and from January 2010 to June 2019 at Samsung Medical Center (institution B). All MRI examinations were performed to evaluate incidental anterior mediastinal lesions detected on CT. Exclusion criteria were overt solid tumor on MRI that showed solid enhancement of a nodule or mass, thymic hyperplasia, and poor image quality or at least one sequence unavailable among T2-weighted, T1-weighted (pre- or postcontrast), or diffusion-weighted images (DWIs) (Fig. 1) [10, 13].
The medical record of each patient was reviewed, and the clinical information (patient age, sex, reason for imaging follow-up, follow-up numbers, and intervals after chest MRI) and pathologic findings if the cystic lesion was resected were recorded.
Imaging protocols and scanners
Imaging studies including baseline and follow-up chest CT scans and MRI were performed with multidetector CT and MRI from different vendors and two magnet strengths (1.5 and 3.0 T). MRIs from institution A (n = 170) were obtained with either 3.0 T scanner (MAGNETOM Skyra, Siemens Healthineers, Erlangen, Germany; n = 137) or 1.5 T scanner (MAGNETOM Avanto, Siemens Healthineers, Erlangen, Germany; n = 33). MRIs from institution B (n = 33) were obtained with 3.0 T scanners from different vendors, either Philips (Ingenia, Philips Healthcare, Best, the Netherlands; n = 13) or Siemens (MAGNETOM Skyra, Siemens Healthineers, Erlangen, Germany; n = 20).
The MRI protocol included at least the following sequences: (1) axial T2-weighted images with fat-suppression, (2) pre- and post-contrast axial T1-weighted images with fat-suppression, and (3) DWIs with corresponding apparent diffusion coefficient (ADC) maps. T2-weighted imaging was performed mostly with breath-hold electrocardiography-gated double inversion recovery T2-weighted imaging. Electrocardiography-gating was applied to obtain better and reliable image quality with high-signal and high-resolution images of the lesion of interest. Images were mostly obtained before and after dynamic administration of gadolinium, predominantly with breath-hold three-dimensional ultrafast gradient-echo fat-saturated T1-weighted imaging (93.6%, 191/204) and occasionally with fat-saturated turbo spin-echo imaging (6.4%, 13/204). Breath-hold DWIs were obtained with b values of 0, b values of 100 or 500 s/mm2, and b values of 700 or 1000 s/mm2. The details of MRI protocols are demonstrated in the Additional file 1: Tables S1 and S2.
All imaging studies were reviewed by two thoracic radiologists (J.C. and S.M.L., with 5 years’ and 10 years’ experience in thoracic radiology, respectively) who were blinded to clinical information. Diametric measurements were performed manually on multiplanar images (axial, sagittal, or coronal) with the largest diameter using electronic calipers. The single largest diameter at each examination was recorded, and a measurable change in the size of anterior mediastinal lesion was defined as a decrease or increase in more than 2.5 mm in the largest size between the two examinations [14, 15].
Imaging features of anterior mediastinal lesions were assessed on MRI, including internal signal intensity on T2-weighted image and pre-contrast T1-weighted image relative to muscle, the presence of diffusion restriction, and the presence of contrast-enhancement of the lesion (smooth thin wall enhancement, nodular enhancing solid portion, eccentric thickening of septa or wall with enhancement). Signal intensities of lesions were measured on representative images with regions of interest covering the entire lesion. Fat-saturated axial pre-contrast T1-weighted images and breath-hold electrocardiography-gated double inversion recovery T2-weighted images were preferentially used for evaluation of T1 and T2 signal intensities, respectively. Based on MRI findings, all lesions were classified into two categories: category 1, probable cysts (or simple cyst) vs. category 2, indeterminate lesion (complex cyst) (Fig. 2). The MRI criteria for probable cyst (or simple cyst) included the following features: 1) no eccentric wall thickening or nodular enhancement except smooth thin wall enhancement, 2) no diffusion restriction, and 3) high signal intensity on T2-weighted image. An indeterminate lesion (complex cyst) was defined when the lesion did not satisfy the above findings. Confidence level of the diagnosis was also rated for probable cysts by 3-point scale (high, intermediate, and low).
For the evaluation of follow-up outcomes, the change in size of lesion and development of new nodular solid portion or irregular wall thickening on both CT and MRI were evaluated and events of surgery and incidence of confirmed tumor were recorded.
Descriptive statistics were demonstrated as mean ± standard deviation, median with interquartile range, or numbers with percentage. Variables were compared using the Fisher’s exact test, Chi-square test or Mann–Whitney U test, as appropriate. Follow-up strategies among physicians and between institutions were compared using the Kruskal–Wallis test or Mann–Whitney U test. All statistical analyses were performed using SPSS software (version 19.0, IBM Corp., Armonk, NY, USA). P values < 0.05 were considered to indicate statistical significance.
A total of 204 patients (mean age 59 ± 11 years; M: F = 111:93) underwent chest MRI. Among these patients, 186 (91.2%) were classified as probable cyst and 18 (8.8%) were classified indeterminate lesion on MRI. The median long-axis diameter of the lesion on MRI was 24 mm (interquartile range [IQR], 18–38; range, 7–113). The patient characteristics of the study population are presented in Table 1. The total follow-up duration from initial to last follow-up imaging in total patients was mean 2.4 years and median 1.7 years (range, 0–12.3 years). The follow-up duration was median 1.9 years (range, 0–12.3 years) for probable cyst and median 0.3 years (range, 0.1–5.5 years) for indeterminate lesions. Except for patients who underwent immediate surgery after chest MRI, the total follow-up duration was median 2.0 years (range, 0–12.3 years) in all patients, median 2.0 years (range, 0–12.3 years) in patients with probable cyst, and median 1.0 years (range, 0.1–5.5 years) in patients with indeterminate lesions.
Imaging characteristics and outcome of probable cysts on chest MRI
Most cysts (75.3%, 140/186) showed unilocular and nonlobulated shape, but 18.3% (34/186) showed unilocular and lobulated shape, and 6.5% (12/186) had multilocular and lobulated shape. Among the patients with probable cysts, 33.3% (62/186) showed high signal intensity on pre-contrast T1-weighted image, and 24.7% (46/186) showed thin and smooth wall enhancement on MRI (Table 2). Follow-up outcomes of patients with probable cysts on MRI are demonstrated in Fig. 3 and Table 3. In patients with more than 2-year follow-up, the size of lesion unchanged in 39.6% (36/91), decreased in 16.5% (15/91), and fluctuated (decreased and increased, or increased and decreased) in 8.8% (8/91). Among those patients, 35.2% (32/91) showed increase in size during follow-up period and six finally underwent surgical resection which all confirmed benign cystic lesion (Fig. 4). None of the patients showed new enhancing nodular solid portion, aggravated wall thickening with thick enhancement, or septation during follow-up exams. A total of 19 (19/91, 20.9%) patients underwent surgery in patients with probable cysts on MRI and 17 patients were confirmed as a thymic cyst, and two patients were confirmed pericardial cyst on pathology. Confidence level of diagnosis was mostly high (180/186, 96.8%), except six patients (6/186, 3.2%) who had small lesions (median 13 mm; IQR, 11–19) with diffuse high signal intensity on pre-contrast T1-weighted image and they were rated as intermediate confidence level of diagnosis.
Imaging characteristics and outcome of indeterminate lesions on chest MRI
Among the 18 patients classified as indeterminate lesion on MRI, eccentric thickening or thick wall was noted in 13 (72.2%) and nodular enhancement was noted in eight (44.4%) (Table 2). The lesion size was significantly larger than that of the lesions classified as probable cysts on MRI (median 39 vs. 24 mm; p = 0.02). In patients with an indeterminate lesion on MRI, 8 patients underwent surgery. Among them, thymoma in three patients (3/8, 37.5%), teratoma in one patient (1/8, 12.5%) were confirmed. Four of the eight remaining patients (4/8, 50%) had thymic cysts. On the histopathological examination of lesions proven to be thymic cysts, all lesions appeared as multilocular thymic cysts with solid portion and/or sebaceous material or demonstrated lymphoid hyperplasia. Among the 10 patients who did not undergo surgery, the size of lesion markedly decreased or nearly regressed (longitudinal size < 10 mm) in four patients on follow-up examinations, suggesting the benign nature of lesion (Fig. 5). The median follow-up interval between the two examinations that showed a marked decrease in size was 3.4 months (IQR, 2.7–4.2). Finally, in patients with an indeterminate lesion on MRI, 16.7% (3/18) were confirmed thymoma and 44.4% (8/18) were confirmed cysts.
Follow-up strategies in clinical practice after chest MRI
In patients with probable cyst except who underwent immediate surgery after chest MRI and underwent follow-up solely for anterior mediastinal cystic lesion (n = 142), the follow-up duration after MRI scan was 1.0 years (IQR: 0–2.0 years; range, 0–10.7 years). Among the patients with probable cysts on MRI, 38.7% (55/142) of patients did not underwent further follow-up after MRI. Among 87 patients who underwent follow-up after MRI, 59.8% (52/87) underwent follow-up for up to 2 years. The median follow-up interval between first imaging follow-up after MRI and baseline MRI was 12 months (IQR, 6–13), which was variable among six physicians (median 12 months for physician 1–3 from institution A; 6, 4, and 9 months for physician 4, 5, and 6 from institution B; range 1–34 months; p = 0.08) and institutions (median 12.0 month in institution A vs. 6 months in institution B; p = 0.01). Proportion of patients without further follow-up after MRI was also different among the physician (50.0% for physician 1, 31.6% for physician 2; 40.0% for physician 3 from institution A; 0% for physician 4; 0% for physician 5; 60.0% for physician 6 from institution B; p = 0.007). The number of follow-up imaging after MRI was different across the physicians (p = 0.001) and institutions (median follow-up numbers, 1 in institution A vs. 3 in institution B; p < 0.001).
In patients with indeterminate lesion except those who underwent immediate surgery after chest MRI and underwent follow-up solely for anterior mediastinal cystic lesion (n = 9), five patients underwent neither further follow-up imaging nor surgery after chest MRI and five patients underwent follow-up with median 1.1 years (IQR: 0.3–1.4 years; range, 0.3–1.8 years) of total follow-up duration after MRI. Follow-up interval between first imaging follow-up after MRI and baseline MRI was median 6.2 months (IQR: 3.0–12.1 months; range, 1.4–17.2 months). The proportion of patients who underwent first follow-up after chest MRI with follow-up intervals of less than 3 months was higher in those with indeterminate lesion than in those with probable cysts on chest MRI (indeterminate lesion vs. probable cysts, 40.0% vs. 2.3%; p = 0.01).
Chest MRI is a widely accepted modality for evaluation of anterior mediastinal lesions. However, clinical outcomes and management of anterior mediastinal cystic lesions diagnosed on MRI is not clearly determined. In our study, 91% of patients were classified as probable cysts among the patients with anterior mediastinal cystic lesions demonstrated on MRI and none of those lesions turned out to be tumor despite changes in size during follow-up. In patients with indeterminate lesions on MRI, 44% had pathologically proven thymic cysts or showed marked decrease in size on follow-up images, suggesting the benign nature of the lesion. Despite varying follow-up intervals according to physicians, most patients with probable cysts were followed up for up to 2 years after chest MRI.
In our study, diagnosing anterior mediastinal cystic lesions using MRI was reliable and accurate for excluding malignancy. All cystic lesions classified as probable cysts on MRI showed no new features suggesting malignant transformation during follow-up such as irregular wall thickening or mural nodules. The follow-up outcome of probable cysts defined by chest MRI in our study were concordant with the findings of Ackman et al., which included only unilocular cysts. Probable cysts in anterior mediastinum diagnosed based on MRI showed a variable change in size on follow-up (decrease, increase or fluctuate) . This is well known and the reason for variable size change in the thymic cysts, can be chronic and recurrent internal hemorrhage and resorption of the internal materials [7, 12]. However, increase in size of theses lesions usually raises concern for malignancy in routine practice. Indeed, in our study, six cystic lesions that were probable thymic cysts based on MRI, were resected due to increase in size. On the basis of our study and Ackman et al., in this situation, follow-up imaging should be considered rather than immediate surgical resection. Furthermore, in case of probable cysts on chest MRI, follow-up may not be necessary.
About 10% of anterior mediastinal cystic lesions were classified as indeterminate. Most lesions showed either of eccentric enhancing wall thickening or nodular enhancement on MRI. For the indeterminate lesion classified based on chest MRI, the differential diagnoses include cystic thymoma, teratoma, or complicated thymic cysts. Actually, lesions cannot be clearly differentiate based on imaging findings, as both benign and malignant disease can demonstrate irregular, eccentric thickening of wall and/or nodular enhancement. These lesions should be followed or resected, depending upon the level of radiologic (i.e., morphology and size of lesion) and clinical suspicion. Interestingly, 40% of patients with indeterminate lesion but who did not undergo surgery, showed marked decrease in size of lesion after median 4 months follow-up, suggesting that the lesions were complicated cysts rather than malignant tumors. Although the number of indeterminate lesions in our study was small, this might enhance the possibility of a more conservative approach even for indeterminate lesions. Therefore, deciding whether to perform surgery after a short follow-up may be considered as a management option in these patients.
Pathologic examinations of the indeterminate lesions proven to be thymic cysts in our study demonstrated histopathologic features of multilocular cysts with a solid portion and/or sebaceous material or lymphoid hyperplasia. Multilocular thymic cysts are thought to be the result of an acquired inflammatory process. Severe acute and chronic inflammation causes cholesterol granuloma formation, fibrovascular proliferation, hemorrhage, necrosis, and/or reactive lymphoid hyperplasia with prominent germinal centers [16, 17]. Those acute and chronic inflammation with lymphoid hyperplasia, granuloma formation or fibrovascular proliferation might present as a solid portion or eccentric nodular thickening on MRI.
Regarding follow-up strategies in patients diagnosed as probable cyst after MRI, it was quite variable according to physicians and institutions. This stems from a different degree of concerns and reliability for chest MRI diagnosing anterior mediastinal cystic lesions differentiating benign cyst from cystic degeneration of malignant tumor among physicians. We observed no adverse outcome (malignant transformation or false negative) of the lesions classified as a probable cyst on MRI. Considering that non-complicated or simple cystic lesions of the other organs including kidney and liver do not usually require follow-up [18,19,20], longer routine follow-up for probable cystic lesions may also not be needed. As chest MRI significantly reduced the number of planned surgical interventions owing to preoperative diagnosis of cysts , it may reduce unnecessary subsequent follow-up examinations for an indeterminate thymic lesion at CT. We believe our results can be evidence for building further guideline for management of anterior mediastinal lesions.
Our study had limitations. First, there was no pathologic confirmation of benignity of all probable cysts demonstrated on MRI. Second, the lesion size was measured and compared using not volumetric measures, but maximum longitudinal diameter on the single best plane among axial, coronal, and sagittal images. As the shape of cysts can change, volumetric analysis may be a good way to accurately show the changes between examinations; however, single measurement of maximum diameter can be a more practical way and is mostly used in the other follow-up guidelines, including renal cysts or pancreatic cystic lesions . Third, follow-up imaging examinations after chest MRI were mostly performed with chest CT, except for two patients; therefore, the evaluation of subtle changes regarding internal characteristics of cystic lesions might be limited in our study. However, overt morphologic changes, which should be certainly alert for malignant tumors, can also be detected on CT.
Diagnosing anterior mediastinal cysts using MRI is reliable. MRI-based management of anterior mediastinal lesions may reduce the number of unnecessary follow-ups and surgeries.
Availability of data and materials
The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.
Apparent diffusion coefficient
International Thymic Malignancy Interest Group
Magnetic resonance imaging
Yoon SH, Choi SH, Kang CH, Goo JM (2018) Incidental anterior mediastinal nodular lesions on chest CT in asymptomatic subjects. J Thorac Oncol 13:359–366
Araki T, Nishino M, Gao W et al (2015) Anterior mediastinal masses in the framingham heart study: prevalence and CT image characteristics. Eur J Radiol Open 2:26–31
Henschke CI, Lee IJ, Wu N et al (2006) CT screening for lung cancer: prevalence and incidence of mediastinal masses. Radiology 239:586–590
McErlean A, Huang J, Zabor EC, Moskowitz CS, Ginsberg MS (2013) Distinguishing benign thymic lesions from early-stage thymic malignancies on computed tomography. J Thorac Oncol 8:967–973
Choe J, Lee SM, Lim S et al (2017) Doubling time of thymic epithelial tumours on CT: correlation with histological subtype. Eur Radiol 27:4030–4036
Kashima J, Okuma Y (2020) Bridging over troubled waters: the doubling time and histological subtypes of thymic epithelial tumors. J Thorac Dis 12:3886–3889
Ackman JB, Chintanapakdee W, Mendoza DP, Price MC, Lanuti M, Shepard JO (2021) Longitudinal CT and MRI characteristics of unilocular thymic cysts. Radiology. https://doi.org/10.1148/radiol.2021203593:203593
Molina PL, Siegel MJ, Glazer HS (1990) Thymic masses on MR imaging. AJR Am J Roentgenol 155:495–500
Tomiyama N, Honda O, Tsubamoto M et al (2009) Anterior mediastinal tumors: diagnostic accuracy of CT and MRI. Eur J Radiol 69:280–288
Carter BW, Okumura M, Detterbeck FC, Marom EM (2014) Approaching the patient with an anterior mediastinal mass: a guide for radiologists. J Thorac Oncol 9:S110-118
Gümüştaş S, Inan N, Sarisoy HT et al (2011) Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging. Eur Radiol 21:2255–2260
Sakuraba M, Tanaka A, Tsuji T, Mishina T (2014) Spontaneous thymic hemorrhage in an adult. Ann Thorac Surg 97:1800–1802
Raptis CA, McWilliams SR, Ratkowski KL, Broncano J, Green DB, Bhalla S (2018) Mediastinal and pleural MR imaging: practical approach for daily practice. Radiographics 38:37–55
Brook OR, Beddy P, Pahade J et al (2016) Delayed growth in incidental pancreatic cysts: are the current American College of radiology recommendations for follow-up appropriate? Radiology 278:752–761
Pandey P, Pandey A, Luo Y et al (2019) Follow-up of incidentally detected pancreatic cystic neoplasms: do baseline MRI and CT features predict cyst growth? Radiology 292:647–654
Suster S, Rosai J (1991) Multilocular thymic cyst: an acquired reactive process. Study of 18 cases. Am J Surg Pathol 15:388–398
Choi YW, McAdams HP, Jeon SC et al (2001) Idiopathic multilocular thymic cyst: CT features with clinical and histopathologic correlation. AJR Am J Roentgenol 177:881–885
Silverman SG, Pedrosa I, Ellis JH et al (2019) Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment. Radiology 292:475–488
Mortelé KJ, Ros PR (2001) Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 21:895–910
Marrero JA, Ahn J, Rajender Reddy K, Americal College of G (2014) ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 109:1328–1347
Ackman JB, Gaissert HA, Lanuti M et al (2016) Impact of nonvascular thoracic MR imaging on the clinical decision making of thoracic surgeons: a 2-year prospective study. Radiology 280:464–474
Megibow AJ, Baker ME, Morgan DE et al (2017) Management of incidental pancreatic cysts: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol 14:911–923
This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (No. NRF-2021R1A4A5032806) and was supported by the Future Medicine 20*30 Project of Samsung Medical Center (#SMX1210781).
Ethics approval and consent to participate
This retrospective study was approved by the institutional review boards, and the requirement for informed consent was waived.
Consent for publication
All authors have no conflicts of interest to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file 1.
Table S1. Representative MRI protocols in institution A. Table S2. Representative MRI protocols in institution B.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Choe, J., Lee, S.M., Ahn, Y. et al. Characteristics and outcomes of anterior mediastinal cystic lesions diagnosed on chest MRI: implications for management of cystic lesions. Insights Imaging 13, 136 (2022). https://doi.org/10.1186/s13244-022-01275-8
- Magnetic resonance imaging
- Mediastinal cyst
- Thymus gland